Age-defining Eye Saviors: A new clinical study of XanMax®

A randomized, double blind, placebo controlled, parallel study has been recently conducted for a duration of 180 days in elderly volunteers.

Statistically significant results demonstrated that XanMax^®​ supports healthy macula through deposition of optimal levels of carotenoid pigments.

Furthermore, the study also demonstrated that the formulation was safe and well tolerated when administrated orally.

XanMax^®​ is an innovative formulation of Zeaxanthin in combination with Lutein which is available from natural Marigold flowers.

XanMax^®​ is part of the Gee Lawson range of speciality ingredients, exclusively distributed in all Europe by LEHVOSS Group.